Opendata, web and dolomites

ACTICAPS

Actiwhey based microencapsulation solution for sustainable food manufacturing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ACTICAPS project word cloud

Explore the words cloud of the ACTICAPS project. It provides you a very rough idea of what is the project "ACTICAPS" about.

business    uniq    substances    eacute    antibiotic    tyson    technologies    meat    nutrition    fast    feed    antibiotics    mrsa    voluntarily    base    integral    life    provides    extended    pilot    besides    disorders    sales    customer    ingredients    safety    delicate    trend    functional    reduce    resistance    manufacturers    solution    shelf    manuals    antimicrobial    hospital    licencing    infections    reg    commercialisation    create    validated    overuse    producers    advantages    acticaps    2022    deaths    bacteria    38m    countless    free    gut    2m    bon    patented    validate    indications    release    91    ratio    companies    causes    actiwhey    coating    hankkija    human    mcdonalds    food    19    70    innovation    11    banning    meet    smithfield    foods    3b    validation    nutritional    team    fill    market    strategy    microencapsulation    revenue    segments    generate    active    bioresearch    diseases    threatening    probiotics    efficiency    feasibility    raisio    tit    valio    app    nutraceuticals    jobs    roadmap    sustainable    regulations    incl    planning    received   

Project "ACTICAPS" data sheet

The following table provides information about the project.

Coordinator
UNIQ BIORESEARCH OY 

Organization address
address: KUURINNIITYNTIE 26
city: ESPOO
postcode: 2750
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Project website http://uniqbioresearch.com/
 Total cost 1˙478˙618 €
 EC max contribution 1˙035˙033 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
 Code Call H2020-SMEINST-2-2015
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-10-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIQ BIORESEARCH OY FI (ESPOO) coordinator 1˙035˙033.00

Map

 Project objective

Overuse of antibiotics in meat production causes human antimicrobial resistance, diseases and gut related disorders, leading to 1.2m life-threatening hospital infections and 19,000 deaths from MRSA-bacteria each year. The best solution is sustainable antibiotic free food production, improved food safety and nutrition value, wider use of probiotics and increased functional foods production.

Companies like Bon Appétit, Tyson Foods, Smithfield, McDonalds, etc. are voluntarily banning antibiotics treated food products. To meet this trend and EU regulations, new cost-effective technologies for processing delicate substances and active ingredients are needed in EU.

Uniq Bioresearch has developed and patented ACTIWHEY® microencapsulation technology that addresses these challenges and provides market leading nutritional efficiency; extended shelf-life, increased food safety and countless new opportunities for food, feed and nutraceuticals manufacturers.

ACTICAPS project aims to 1) reduce the microencapsulation costs by 91%; 2) achieve 70% fill-coating ratio; 3) improve controlled release and other key advantages; 4) set up pilot production for market validation and dissemination; 5) create a scale-up package, incl. process planning strategy, production manuals and licencing concept; 6) validate the innovation in 3 market segments with most potential for fast market uptake.

This project is an integral part of our long-term development roadmap. Our market uptake potential is based on 11 years of R&D and business success; established key customer base; validated patented technology, experienced team and detailed feasibility study for identifying the best business and commercialisation strategy.

We target a high growth €7.3b market and expect to generate sales revenue of €38m and create more than 50 new jobs by 2022. Besides current customer base, we have received potential order indications from market-leading feed and food producers like Hankkija, Raisio, Valio etc.

 Deliverables

List of deliverables.
Dissemination report Documents, reports 2019-05-30 17:01:51
Report on microcapsules enhanced commercial product performance Documents, reports 2019-04-30 18:24:42
Project website Websites, patent fillings, videos etc. 2019-05-30 15:02:20
Project flyer Websites, patent fillings, videos etc. 2019-05-30 15:02:25

Take a look to the deliverables list in detail:  detailed list of ACTICAPS deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ACTICAPS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ACTICAPS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.3.2.)

ASEPTIC-VACBID (2016)

Energy Saving Aseptic System to Empty Concentrates out of Aseptic Bags for the Juice Production Process.

Read More  

EECHYMA (2015)

Eco-efficient high-yield production of antioxidant compounds from microalgae

Read More  

HEALTHSTOCK (2015)

Fodder for for HEALTHier animals and improved liveSTOCK production

Read More